Rates and causative pathogens of surgical site infections attributed to liver transplant procedures and other hepatic, biliary, or pancreatic procedures, 2015-2018
- PMID: 33617680
- PMCID: PMC8380253
- DOI: 10.1111/tid.13589
Rates and causative pathogens of surgical site infections attributed to liver transplant procedures and other hepatic, biliary, or pancreatic procedures, 2015-2018
Abstract
Liver transplant recipients are at high risk for surgical site infections (SSIs). Limited data are available on SSI epidemiology following liver transplant procedures (LTPs). We analyzed data on SSIs from 2015 to 2018 reported to CDC's National Healthcare Safety Network to determine rates, pathogen distribution, and antimicrobial resistance after LTPs and other hepatic, biliary, or pancreatic procedures (BILIs). LTP and BILI SSI rates were 5.7% and 5.9%, respectively. The odds of SSI after LTP were lower than after BILI (adjusted odds ratio = 0.70, 95% confidence interval 0.57-0.85). Among LTP SSIs, 43.1% were caused by Enterococcus spp., 17.2% by Candida spp., and 15.0% by coagulase-negative Staphylococcus spp. (CNS). Percentages of SSIs caused by Enterococcus faecium or CNS were higher after LTPs than BILIs, whereas percentages of SSIs caused by Enterobacteriaceae, Enterococcus faecalis, or viridans streptococci were higher after BILIs. Antimicrobial resistance was common in LTP SSI pathogens, including E. faecium (69.4% vancomycin resistant); Escherichia coli (68.8% fluoroquinolone non-susceptible and 44.7% extended spectrum cephalosporin [ESC] non-susceptible); and Klebsiella pneumoniae and K. oxytoca (39.4% fluoroquinolone non-susceptible and 54.5% ESC non-susceptible). National LTP SSI pathogen and resistance data can help prioritize studies to determine effective interventions to prevent SSIs and reduce antimicrobial resistance in liver transplant recipients.
Keywords: drug resistance; liver transplantation; microbial; surgical wound infection.
© 2021 The Authors. Transplant Infectious Disease published by Wiley Periodicals LLC. This article has been contributed to by US Government employees and their work is in the public domain in the USA.
Conflict of interest statement
The authors of this manuscript have no conflicts of interest to disclose.
References
-
- Organ Procurement and Transplantation Network . National Data. https://optn.transplant.hrsa.gov/data/view‐data‐reports/national‐data/#. Accessed May 27, 2020.
-
- Scientific Registry of Transplant Recipients . Transplant Center Search Results. https://www.srtr.org/transplant‐centers/?&organ=liver&recipientType=adul.... Accessed May 27, 2020.
-
- Scientific Registry of Transplant Recipients . OPTN/SRTR 2018 Annual Data Report: Liver. https://srtr.transplant.hrsa.gov/annual_reports/2018/Liver.aspx. Accessed May 28, 2020.
-
- Viehman JA, Clancy CJ, Clarke L, et al. Surgical site infections after liver transplantation: emergence of multidrug‐resistant bacteria and implications for prophylaxis and treatment strategies. Transplantation. 2016;100(10):2107‐2114. - PubMed
-
- Natori Y, Kassar R, Iaboni A, et al. Surgical site infections after liver transplantation: prospective surveillance and evaluation of 250 transplant recipients in Canada. Infect Control Hosp Epidemiol. 2017;38(9):1084‐1090. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
